logo
In John Mozeliak's final trade deadline with Cardinals, ‘long-term view' of team was the priority

In John Mozeliak's final trade deadline with Cardinals, ‘long-term view' of team was the priority

New York Times4 days ago
SAN DIEGO — In his final season as the St. Louis Cardinals president of baseball operations, John Mozeliak acknowledged the obvious.
He did not want to sell, but his club had not performed well enough to warrant any other option. During this transition season — one that prioritized player development from the start — building towards the future was the sensical solution. By trading Ryan Helsley, Phil Maton and Steven Matz for an assortment of prospects, Mozeliak hopes he's accomplished that, though the organization likely won't see the true payoff from these trades for multiple seasons.
Advertisement
'The goal of this trading deadline was about the future,' Mozeliak said. 'I don't think it's necessarily about the immediate future. It's about the long-term view of the St. Louis Cardinals.'
Speaking on a Zoom call from his office at Busch Stadium, Mozeliak touched on a variety of trade deadline topics, ranging from why he only traded pending free agents, why minor-league talent — not soon-to-be-major-league-ready talent — was the top target in returns and why he did not trade any of his position players, despite a high interest level from rival clubs.
It was not an easy decision for the front office, but it was a familiar one. The Cardinals have sold just twice throughout Mozeliak's 18-year tenure, but this year's sell-off marks their second in the last three years. However this year's purpose was much different. While the Cardinals also only traded expiring contracts in 2023, Mozeliak's first sell season, he targeted pitching depth and upper-level minor-league talent in efforts to avoid a rebuild.
That was not the case this year. Mozeliak, with input from incoming successor Chaim Bloom, opted for best overall talent in returns for his top three relievers — a clear sign that bridge year will span much longer than first advertised.
'We went into this deadline trying to move our expiring contracts,' Mozeliak said. 'We were able to do that. The goal of these moves was to position the organization for future talent — not necessarily just guys that are knocking on the door for big-league opportunities next year. It was really about trying to create as much prospect value as possible, and we felt we achieved that.
'It's a cliche answer, but (we were looking) for best talent available.'
St. Louis acquired six total prospects: shortstop Jesus Baez and right-handers Nate Dohm and Frank Elissalt from the New York Mets for Helsley, corner infielder Blaze Jordan from the Boston Red Sox for Matz, and pitching prospects Mason Molina (RHP) and Skylar Hales (LHP) from the Texas Rangers for Maton. Though the deadline is over, plenty of questions remain.
Advertisement
The Cardinals garnered significant interest on an assortment of position players with multiple remaining years of control. The most popular area? Their left-handed hitters. Rival clubs consistently inquired about Brendan Donovan and Lars Nootbaar (two remaining years of control) and Alec Burleson (three remaining years of control). But St. Louis asked for a remarkably high return, with one rival executive describing the ask as 'insane' and another terming it as 'sky-high.'
'We got hit a lot on our left-handed hitters,' Mozeliak said. 'But none of the types of offers we were getting for those players were compelling for us to do it. To say we went into this solely with just the focus of moving three expiring contracts is not necessarily accurate, but we were not motivated to move players that we had under control unless we were, to put it mildly, blown away. And we just weren't.'
So the Cardinals instead kept their position-playing core. Nootbaar and Nolan Gorman are on the 10-day IL, but both are expected to return to the big-league club at some point over the upcoming trip against the San Diego Padres and Los Angeles Dodgers. That will create another logjam for manager Oli Marmol, who has had to juggle playing time all year.
When asked how he envisioned that shaking out, Mozeliak hinted it would be something to monitor over the offseason when Bloom takes over the organization.
'Maybe we reflect on it a little bit more in the sense of what does this really mean for next year?' Mozeliak said. 'When the question was asked if we were not willing to move players under control, the answer is the timing wasn't now. The question is a good one, and one that will ultimately be resolved probably over the next six months.'
Advertisement
Helsley was the Cardinals' big ticket, and rival evaluators had mixed reviews about his return.
With no true front-line starting pitcher on the market, contending clubs pivoted to maximizing their bullpen — significantly upping the market cost. St. Louis traded Helsley on Wednesday afternoon with over 24 hours remaining before the deadline. Why did Mozeliak feel that was the right time?
'My concern was that there were four big-name closers out there, and obviously two of them had multiple years of control,' he said. 'In our case, Helsley had two months. I was cognizant of how far we had leverage. What I didn't want to have happened was to take this into the final day, and not be in a position to try to do the best deal possible. A lot of times in this business, people think the longer you wait, the better the deal. I was scared that the longer we wait, the music might stop and we might still be standing.'
Jhoan Duran (traded from the Minnesota Twins to the Philadelphia Phillies), David Bednar (dealt to the New York Yankees by the Pittsburgh Pirates) and Camilo Doval (acquired by the Yankees from the San Francisco Giants) all have multiple years of team control remaining. That's to say nothing of the biggest relief pitching deal made: The San Diego Padres stunned the industry by trading for Athletics' closer Mason Miller, who will not be a free agent until 2030.
Helsley's value, while considerably high given the market, was not going to match the above.
'You can see there were other closers that were traded that have years of control, and their returns were different,' Mozeliak said. 'We were trying to focus on maybe some young starting pitching, but as you can tell, that was not really our highest level of return. It came down to the potential suitors that we were speaking with, and we tried to navigate it the best we could, but ultimately ended up deciding to go with the players that we thought had the highest upside.'
With their top three relievers gone, the Cardinals have three active roster spots to fill. One will undoubtedly go to Ryan Fernandez, who has turned things around in Memphis with a 3.12 ERA after a disastrous start to the season in April.
Advertisement
As for currently rostered players, Mozeliak said left-hander JoJo Romero will see more high-leverage situations. Riley O'Brien and Gordon Graceffo were also identified as pitchers who will see more distinctive roles in the bullpen. St. Louis has used Kyle Leahy in late innings semi-regularly; that usage is expected to increase as well.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MetLife (MET) To Report Earnings Tomorrow: Here Is What To Expect
MetLife (MET) To Report Earnings Tomorrow: Here Is What To Expect

Yahoo

time21 minutes ago

  • Yahoo

MetLife (MET) To Report Earnings Tomorrow: Here Is What To Expect

Global insurance giant MetLife (NYSE:MET) will be reporting results this Wednesday afternoon. Here's what investors should know. MetLife beat analysts' revenue expectations by 3% last quarter, reporting revenues of $18.83 billion, up 10.6% year on year. It was a slower quarter for the company, with a significant miss of analysts' book value per share estimates and a miss of analysts' EPS estimates. Is MetLife a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting MetLife's revenue to be flat year on year at $18.64 billion, in line with its flat revenue from the same quarter last year. Adjusted earnings are expected to come in at $2.16 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. MetLife has missed Wall Street's revenue estimates four times over the last two years. Looking at MetLife's peers in the life insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Corebridge Financial delivered year-on-year revenue growth of 5.8%, beating analysts' expectations by 7.3%, and Lincoln Financial Group reported revenues up 4.4%, topping estimates by 1.1%. Lincoln Financial Group traded up 7.8% following the results. Read our full analysis of Corebridge Financial's results here and Lincoln Financial Group's results here. Debates around the economy's health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the life insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.9% on average over the last month. MetLife is down 5.3% during the same time and is heading into earnings with an average analyst price target of $94.14 (compared to the current share price of $75). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

HubSpot (HUBS) Reports Q2: Everything You Need To Know Ahead Of Earnings
HubSpot (HUBS) Reports Q2: Everything You Need To Know Ahead Of Earnings

Yahoo

time21 minutes ago

  • Yahoo

HubSpot (HUBS) Reports Q2: Everything You Need To Know Ahead Of Earnings

Sales and marketing software maker HubSpot (NYSE:HUBS) will be announcing earnings results this Wednesday afternoon. Here's what to look for. HubSpot beat analysts' revenue expectations by 2% last quarter, reporting revenues of $714.1 million, up 15.7% year on year. It was a strong quarter for the company, with an impressive beat of analysts' billings estimates and a solid beat of analysts' EBITDA estimates. It added 10,319 customers to reach a total of 258,258. Is HubSpot a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting HubSpot's revenue to grow 16% year on year to $739.3 million, slowing from the 20.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.12 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. HubSpot has only missed Wall Street's revenue estimates once over the last two years, exceeding top-line expectations by 3.1% on average. Looking at HubSpot's peers in the sales and marketing software segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Freshworks delivered year-on-year revenue growth of 17.5%, beating analysts' expectations by 2.9%, and BigCommerce reported revenues up 3.2%, topping estimates by 1.3%. Freshworks traded down 2.5% following the results while BigCommerce was up 4.6%. Read our full analysis of Freshworks's results here and BigCommerce's results here. The euphoria surrounding Trump's November win lit a fire under major indices, but potential tariffs have caused the market to do a 180 in 2025. While some of the sales and marketing software stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 3% on average over the last month. HubSpot is down 7.8% during the same time and is heading into earnings with an average analyst price target of $736.74 (compared to the current share price of $512.20). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Primerica Earnings: What To Look For From PRI
Primerica Earnings: What To Look For From PRI

Yahoo

time21 minutes ago

  • Yahoo

Primerica Earnings: What To Look For From PRI

Financial services company Primerica (NYSE:PRI) will be reporting results this Wednesday after market hours. Here's what to expect. Primerica beat analysts' revenue expectations by 2.1% last quarter, reporting revenues of $803.6 million, up 9.4% year on year. It was a mixed quarter for the company, with net premiums earned in line with analysts' estimates but a slight miss of analysts' book value per share estimates. Is Primerica a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Primerica's revenue to grow 6.1% year on year to $786.1 million, slowing from the 9.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $5.20 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Primerica has missed Wall Street's revenue estimates four times over the last two years. Looking at Primerica's peers in the life insurance segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Corebridge Financial delivered year-on-year revenue growth of 5.8%, beating analysts' expectations by 7.3%, and Lincoln Financial Group reported revenues up 4.4%, topping estimates by 1.1%. Lincoln Financial Group traded up 7.8% following the results. Read our full analysis of Corebridge Financial's results here and Lincoln Financial Group's results here. The outlook for 2025 remains clouded by potential trade policy changes and corporate tax discussions, which could impact business confidence and growth. While some of the life insurance stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 2.9% on average over the last month. Primerica is down 2.8% during the same time and is heading into earnings with an average analyst price target of $307.29 (compared to the current share price of $265.39). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store